Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 1
2011 2
2012 3
2013 1
2014 1
2015 3
2016 4
2017 3
2018 7
2019 9
2020 7
2021 12
2022 19
2023 24
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Targeting integrin pathways: mechanisms and advances in therapy.
Pang X, He X, Qiu Z, Zhang H, Xie R, Liu Z, Gu Y, Zhao N, Xiang Q, Cui Y. Pang X, et al. Among authors: xie r. Signal Transduct Target Ther. 2023 Jan 2;8(1):1. doi: 10.1038/s41392-022-01259-6. Signal Transduct Target Ther. 2023. PMID: 36588107 Free PMC article. Review.
Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study.
Choueiri TK, Eto M, Motzer R, De Giorgi U, Buchler T, Basappa NS, Méndez-Vidal MJ, Tjulandin S, Hoon Park S, Melichar B, Hutson T, Alemany C, McGregor B, Powles T, Grünwald V, Alekseev B, Rha SY, Kopyltsov E, Kapoor A, Alonso Gordoa T, Goh JC, Staehler M, Merchan JR, Xie R, Perini RF, Mody K, McKenzie J, Porta CG. Choueiri TK, et al. Among authors: xie r. Lancet Oncol. 2023 Mar;24(3):228-238. doi: 10.1016/S1470-2045(23)00049-9. Lancet Oncol. 2023. PMID: 36858721 Clinical Trial.
A Randomized Study of Lenvatinib 18 mg vs 24 mg in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer.
Brose MS, Panaseykin Y, Konda B, de la Fouchardiere C, Hughes BGM, Gianoukakis AG, Joo Park Y, Romanov I, Krzyzanowska MK, Leboulleux S, Binder TA, Dutcus C, Xie R, Taylor MH. Brose MS, et al. Among authors: xie r. J Clin Endocrinol Metab. 2022 Feb 17;107(3):776-787. doi: 10.1210/clinem/dgab731. J Clin Endocrinol Metab. 2022. PMID: 34664662 Free PMC article. Clinical Trial.
[A mini-review on anti-tumor effect of cannabidiol].
Xie R, Hao DL, Yang JY, Jia LY, Wang PQ, Zhao Y, Chen YJ, Zhao QH. Xie R, et al. Zhongguo Zhong Yao Za Zhi. 2022 Dec;47(24):6541-6550. doi: 10.19540/j.cnki.cjcmm.20220906.601. Zhongguo Zhong Yao Za Zhi. 2022. PMID: 36604902 Review. Chinese.
Aglycone sterics-selective enzymatic glycan remodeling.
Mao A, Zhang Y, Wang G, Zhong T, Chen X, Wang H, Xie R, Wang X, Ding L, Ju H. Mao A, et al. Among authors: xie r. iScience. 2022 Jun 13;25(7):104578. doi: 10.1016/j.isci.2022.104578. eCollection 2022 Jul 15. iScience. 2022. PMID: 35789841 Free PMC article.
Traceless Protein-Selective Glycan Labeling and Chemical Modification.
Zheng X, Li Y, Cui T, Yang J, Meng X, Wang H, Chen L, He J, Chen N, Meng L, Ding L, Xie R. Zheng X, et al. Among authors: xie r. J Am Chem Soc. 2023 Nov 1;145(43):23670-23680. doi: 10.1021/jacs.3c07889. Epub 2023 Oct 19. J Am Chem Soc. 2023. PMID: 37857274
90 results